Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly
Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise
0 Comments
Comments 0
No comments yet. Be the first to comment!